Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

Henrik Watz,1 Kathleen Rickard,2 Tara Rheault,2 Thomas Bengtsson,3 Dave Singh4 1Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany; 2Verona Pharma Plc, Raleigh, NC, USA; 3StatMind...

Full description

Bibliographic Details
Main Authors: Watz H, Rickard K, Rheault T, Bengtsson T, Singh D
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:International Journal of COPD
Subjects:
phosphodiesterase inhibitors
pulmonary disease
chronic obstructive
signs and symptoms
respiratory
drug therapy
Online Access:https://www.dovepress.com/symptom-improvement-following-treatment-with-the-inhaled-dual-phosphod-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/symptom-improvement-following-treatment-with-the-inhaled-dual-phosphod-peer-reviewed-article-COPD

Similar Items